STEREOSPECIFIC REVERSAL OF STRESS-INDUCED ANHEDONIA BY MIANSERIN AND ITS (+)-ENANTIOMER

被引:37
作者
CHEETA, S
BROEKKAMP, C
WILLNER, P
机构
[1] UNIV COLL SWANSEA, DEPT PSYCHOL, SWANSEA SA2 8PP, W GLAM, WALES
[2] NV ORGANON, CENT NERVOUS SYST PHARMACOL, 5340 BH OSS, NETHERLANDS
关键词
CHRONIC MILD STRESS; ANHEDONIA; SUCROSE DRINKING; PLACE CONDITIONING; MIANSERIN; (+)-MIANSERIN; DOPAMINE; RAT;
D O I
10.1007/BF02247488
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Chronic sequential exposure to a variety of mild unpredictable stressors has previously been found to depress the consumption of a dilute (1%) sucrose solution and to inhibit food-induced place preference conditioning, In the present study, using a simplified version of the mild stress procedure, the decreased sucrose intake was reversed by chronic (4 weeks) treatment with the atypical antidepressant mianserin. The racemic compound (+/-)-mianserin (5 mg/kg per day) and one of its enantiomers, (+)-mianserin (2.5 mg/kg) were effective in this model, a lower dose of (+/-)-mianserin (2.5 mg/kg), and the other enantiomer, (-)-mianserin (2.5 mg/kg), were ineffective. Vehicle-treated stressed animals were also subsensitive to food reward in the place conditioning procedure: normal place preference conditioning was reinstated by chronic treatment with (+)-mianserin (5 mg/kg) or (+)-mianserin, but not by the lower dose of (+/-)mianserin (2.5 mg/kg) or by (-)-mianserin. Raclopride (100 ug/kg) reinstated the decrease in sucrose intake in stressed animals successfully treated with (+/-)- or (+)mianserin, The results suggest that (+)-mianserin is the active enantiomer in reversing chronic mid stress-induced anhedonia, and further support the hypothesis of a dopaminergic mechanism of antidepressant action in this paradigm.
引用
收藏
页码:523 / 528
页数:6
相关论文
共 42 条
[1]
*AM PSYCH ASS, 1987, DSM 111 R DIAGN STAT
[2]
[Anonymous], 1971, STAT PRINCIPLES EXPT
[3]
ARNT J, 1984, POL J PHARMACOL PHAR, V36, P221
[4]
BLOCKADE OF PRESYNAPTIC ALPHA-RECEPTORS AND OF AMINE UPTAKE IN RAT-BRAIN BY ANTIDEPRESSANT MIANSERINE [J].
BAUMANN, PA ;
MAITRE, L .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1977, 300 (01) :31-37
[5]
Bozarth M. A., 1987, METHODS ASSESSING RE
[6]
Carr H.C., 1989, NEUROPHARMACOLOGICAL
[7]
CHEETA S, 1992, J PSYCHOPHARMACOL, V6, P55
[8]
POTENTIAL NEUROLEPTIC AGENTS .4. CHEMISTRY, BEHAVIORAL PHARMACOLOGY, AND INHIBITION OF [H-3] SPIPERONE BINDING OF 3,5-DISUBSTITUTED N-[(1-ETHYL-2-PYRROLIDINYL)METHYL]-6-METHOXYSALICYLAMIDES [J].
DEPAULIS, T ;
KUMAR, Y ;
JOHANSSON, L ;
RAMSBY, S ;
HALL, H ;
SALLEMARK, M ;
ANGEBYMOLLER, K ;
OGREN, SO .
JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (01) :61-69
[9]
PHARMACO-EEG STUDY OF 6-AZAMIANSERIN (ORG 3770) - DISSOCIATION OF EEG AND PHARMACOLOGIC PREDICTORS OF ANTI-DEPRESSANT ACTIVITY [J].
FINK, M ;
IRWIN, P .
PSYCHOPHARMACOLOGY, 1982, 78 (01) :44-48
[10]
DECREASE IN HYPOTHALAMIC EPINEPHRINE CONCENTRATION AND OTHER NEUROCHEMICAL CHANGES PRODUCED BY QUINPIROLE, A DOPAMINE AGONIST, IN RATS [J].
FULLER, RW ;
HEMRICKLUECKE, SK .
JOURNAL OF NEURAL TRANSMISSION, 1985, 61 (3-4) :161-173